srpt news - Search News

Sarepta, SRPT

Sarepta Therapeutics Inc (SRPT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Sarepta Therapeutics Inc (SRPT) reports a 75% increase in quarterly revenues and outlines ambitious growth plans for 2025.

Zacks.com on MSN · 3d

Sarepta Therapeutics (SRPT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

The price trend for Sarepta Therapeutics (SRPT) has been bearish lately and the stock has lost 9% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon,

Business Insider · 2d

Evercore ISI Keeps Their Buy Rating on Sarepta Therapeutics (SRPT)

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) yesterday and set a price

23h

Sarepta Therapeutics’ (SRPT) Sell Rating Reiterated at HC Wainwright

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating reiterated by stock analysts at HC ...

Hosted on MSN2d

Sarepta Q4 Earnings Lag Estimates, Revenues Gain on Gene Therapy Sales

Sarepta Therapeutics, Inc. SRPT reported fourth-quarter 2024 earnings per share (EPS) of $1.50, which missed the Zacks ...

Nasdaq3d

SAREPTA THERAPEUTICS Earnings Results: $SRPT Reports Quarterly Earnings

SAREPTA THERAPEUTICS ($SRPT) posted quarterly earnings results on Wednesday, February 26th. The company reported earnings of $1.50 per share, missing estimates of $1. ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Sarepta, SRPT

Trending now